70255-025 : Braftovi 75 mg Oral Capsule
| NDC: | 70255-025 |
| Labeler: | Array Biopharma Inc. |
| Product Type: | Human Prescription Drug |
| Drug Name: |  Braftovi |
| Dosage Form: | Oral Capsule |
| Application #: | NDA210496 |
| Rev. Date: |
Appearance:
| Markings: | A;LGX;75mg |
| Shapes: |
Capsule |
| Colors: |
 Pink /
 White |
| Size (mm): | 23 |
| Segments: * | 1 |
* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines. | |
NDC Package Codes:
- 70255-025-01: 2 BOTTLE IN 1 CARTON (70255‑025‑01) > 90 CAPSULE IN 1 BOTTLE (70255‑025‑02)
- 70255-025-03: 2 BOTTLE IN 1 CARTON (70255‑025‑03) > 60 CAPSULE IN 1 BOTTLE (70255‑025‑04)
- 70255-025-05: 90 CAPSULE IN 1 BOTTLE (70255‑025‑05)
- 70255-025-06: 60 CAPSULE IN 1 BOTTLE (70255‑025‑06)
Active Ingredients:
- Encorafenib
Dosage Strength:
- 75 mg
Inactive Ingredients:
- Copovidone K25-31
- Poloxamer 188
- Microcrystalline Cellulose
- Succinic Acid
- Crospovidone
- Silicon Dioxide
- Magnesium Stearate
- Gelatin, Unspecified
- Titanium Dioxide
- Ferric Oxide Red
- Ferric Oxide Yellow
- Ferrosoferric Oxide
- Shellac
- Propylene Glycol /
Related Products:
Based on records with the same trade name.- 70255-020 Braftovi 50 mg Oral Capsule by Array Biopharma Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 70255-020Next: 70257-051 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.